Guidelines for Good Database Selection and use in Pharmacoepidemiology Research

被引：100

作者：

Hall, Gillian C.

Sauer, Brian ^{[1
,2
]}

Bourke, Alison ^{[3
]}

Brown, Jeffrey S. ^{[4
,5
]}

Reynolds, Matthew W. ^{[6
]}

Lo Casale, Robert ^{[7
]}

机构：

[1] Univ Utah, Salt Lake City VA IDEAS Ctr, Salt Lake City, UT USA

[2] Univ Utah, Div Epidemiol, Salt Lake City, UT USA

[3] CSD Med Res, London, England

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Harvard Pilgrim Hlth Care Inst, Boston, MA USA

[6] United BioSource Corp, Lexington, MA USA

[7] Merck & Co Inc, Dept Epidemiol, West Point, PA USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷 / 01期

关键词：

Health databases; research design; epidemiology; pharmaceuticals; guidance; RETROSPECTIVE DATABASE; TASK-FORCE; VALIDATION;

D O I：

10.1002/pds.2229

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

100235 [预防医学];

摘要：

The use of healthcare databases in research provides advantages such as increased speed, lower costs and limitation of some biases. However, database research has its own challenges as studies must be performed within the limitations of resources, which often are the product of complex healthcare systems. The primary purpose of this document is to assist in the selection and use of data resources in pharmacoepidemiology, highlighting potential limitations and recommending tested procedures. This guidance is presented as a detailed text with a checklist for quick reference and covers six areas: selection of a database, use of multiple data resources, extraction and analysis of the study population, privacy and security, quality and validation procedures and documentation. Copyright (C) 2011 John Wiley & Sons, Ltd.

引用

页码：1 / 10

页数：10

共 13 条

[1]

Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part I [J].